Brugada syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(40 intermediate revisions by 8 users not shown)
Line 3: Line 3:
   Name          = Brugada syndrome |
   Name          = Brugada syndrome |
   Image          = BrugadaS.jpg|
   Image          = BrugadaS.jpg|
   Caption        = ECG findings of Brugada Syndrome|
   Caption        = ECG in Type I Brugada Pattern|
  DiseasesDB    = 31999 |
  ICD10          = {{ICD10|I|42|8|i|30}} |
  ICD9          = {{ICD9|746.89}} |
  ICDO          = |
  OMIM          = 601144 |
  MedlinePlus    = |
  MeshID        = D053840 |
}}
}}
'''For patient information, click [[Brugada syndrome (patient information)|here]]'''


{{Brugada syndrome}}
{{Brugada syndrome}}
Line 17: Line 11:
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}


{{SK}} Sudden unexpected death syndrome; SUDS
{{SK}} Sudden unexpected death syndrome; sudden unexplained death syndrome; SUDS; sudden unexpected nocturnal death syndrome; sudden unexplained nocturnal death syndrome; SUNDS; in the Phillipines ''bangungut'' (to rise and moan in sleep); in Thailand ''lai tai''; in Laos ''Dab tsog'' and in Japan ''Pokkuri disease''
==Differential Diagnosis==


==Characteristics==
==[[Brugada syndrome overview|Overview]]==


*Characterized by a coved-type ST-segment elevation in the right precordial leads
==[[Brugada syndrome classification|Classification]]==
*The Brugada ECG is often concealed, but can be unmasked or modulated by a number of drugs and pathophysiological states including sodium channel blockers, a febrile state, vagotonic agents, tricyclic antidepressants, as well as cocaine and Propranolol intoxication.


==Lithium Treatment and Brugada Syndrome==
==[[Brugada syndrome historical perspective|Historical Perspective]]==
Administration of [[Lithium]] can result in EKG manifestations of the Brugada syndrome. <ref>Pirotte  MJ,  Mueller  JG,  Poprawski  T.  A case report of Brugada-type  electrocardiographic changes in a patient taking lithium. Am J Emerg Med.  2008;  26:  113.</ref><ref>Wright D, Salehian O. Brugada-Type Electrocardiographic Changes Induced by Long-Term Lithium Use. Circulation, FRCPC2010;122:e418-e419</ref>.  [[Syncope]] and [[sudden cardiac death]] have been observed in these patients.<ref>Laske  C,  Soekadar  SR,  Laszlo  R,  Plewnia  C.  Brugada syndrome in a patient treated with lithium. Am J Psychiatry.  2007;  164:  1440–1441. </ref> The putative role of [[lithium]] has been suggested in so far as withdrawal of [[lithium]] results in either 1) normalization of the ECG or 2) conversion of the Brugada pattern to type 2 or 3. The appearance of Brugada type EKG patterns does not require toxic [[lithium]] levels.


==Diagnosis==
==[[Brugada syndrome pathophysiology|Pathophysiology]]==


==Sodium Challenge==
==[[Brugada syndrome differential diagnosis|Differentiating Brugada syndrome from other Diseases]]==


* Drugs that can be used
==[[Brugada syndrome epidemiology and demographics|Epidemiology and Demographics]]==
** Ajmaline 1 mg/kg/5 min IV
** Flecainide 2 mg/kg/10 min IV or 400 mg PO
** Procainamide 10 mg/kg/10 min IV
** Pilsicainide 1 mg/kg/10 min IV
* The sodium challenge should be terminated when
# Diagnostic Type 1 ST-segment elevation or Brugada ECG, develops
# ST segment in Type 2 increases by ≥2 mm
# Premature ventricular beats or other arrhythmias develop
# QRS widens to ≥130% of baseline


==Arrhythmias==
==[[Brugada syndrome risk factors|Risk Factors]]==


# Polymorphic VT resembling a rapid Torsade de Pointes (TdP)
==[[Brugada syndrome screening|Screening]]==
# Monomorphic VT is observed infrequently
 
# VT/VF often terminates spontaneously in patients with the Brugada syndrome which may explain why patients wake up at night after episodes of agonal respiration caused by the arrhythmia.
==[[Brugada syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 
==Brugada syndrome diagnosis|Diagnosis==
[[Brugada syndrome diagnostic criteria|Diagnostic Criteria]] | [[Brugada syndrome history and symptoms|History and Symptoms]] | [[Brugada syndrome physical examination|Physical Examination]] | [[Brugada syndrome laboratory findings|Laboratory Findings]] | [[Brugada syndrome electrocardiogram|Electrocardiogram]] | [[Brugada syndrome chest x ray|Chest X Ray]] | [[Brugada syndrome echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Brugada syndrome electrophysiologic studies|Electrophysiologic Studies]] | [[Brugada syndrome genetic testing|Genetic Testing]]


==Treatment==
==Treatment==
[[Brugada syndrome medical therapy|Medical Therapy]] | [[Brugada syndrome drugs to avoid|Drugs to Avoid]] | [[Brugada syndrome drugs to preferably avoid|Drugs to Preferably Avoid]] | [[Brugada syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Brugada syndrome future or investigational therapies|Future or Investigational Therapies]]


The cause of death in Brugada syndrome is [[ventricular fibrillation]].The episodes of syncope (fainting) and sudden death (aborted or not) are caused by fast polymorphic ventricular tachycardias or ventricular fibrillation. These arrhythmias appear with no warning.  While there is no exact treatment modality that reliably and totally prevents ventricular fibrillation from occurring in this syndrome, treatment lies in termination of this lethal [[arrhythmia]] before it causes death. This is done via implantation of an [[implantable cardioverter-defibrillator]] (ICD), which continuously monitors the heart rhythm and will [[defibrillation|defibrillate]] an individual if ventricular fibrillation is noted. Some recently performed studies had evaluated the role of quinidine, a Class Ia antiarrythmic drug, for decreasing VF episodes occurring in this syndrome. Quinidine was found to decrease number of VF episodes and correcting spontaneous ECG changes, possibly via inhibiting I</sup>to channels.<ref name="pmid15381640">{{cite journal |author=Belhassen B, Glick A, Viskin S |title=Efficacy of quinidine in high-risk patients with Brugada syndrome |journal=Circulation |volume=110 |issue=13 |pages=1731–7 |year=2004 |pmid=15381640 |doi=10.1161/01.CIR.0000143159.30585.90}}</ref> Those with risk factors for [[coronary artery disease]] may require an angiogram before ICD implantation.
==Case Studies==
 
[[Brugada syndrome case study one|Case #1]]
* Aborted sudden death are at high risk for recurrence and should receive an ICD
* VT storm has been successfully treated with Isoproterenol.  The mechanism is thought to be augmenting the cardiac L type channel.
* Asymptomatic patients require risk stratification and clinical judegement to help guide therapy
* Quinidine (class IA sodium channel blocker) blocks the Ito current and is proven to suppress spontaneous VF
* Cilostazol (phosphodiesterase III inhibitor that increases inward L type calcium channel current and reported to suppress spontaneous VF
* Bepridil suppress spontaneous VF probably through blocking Ito current
* Medical therapy alone with the above agents is currently not evaluated in randomized trials and should not be used as loan therapy.


==See also==
==Related Chapters==
* [[Cardiac action potential]]
* [[Cardiac action potential]]
* [[Genetics]]
* [[Genetics]]
* [[Ion channel]]
* [[Ion channel]]
* [[Tambocor]]
* [[Tambocor]]
==References==
{{Reflist|2}}
==External links==
* [http://www.genetests.org/profiles/brugada GeneReviews: Brugada syndrome]
* Algado et al: http://www.medspain.com/ant/n13_jun00/Brugada.htm
* Behr: http://www.c-r-y.org.uk/long_qt_syndrome.htm
* [http://www.brugada.org The Ramon Brugada Senior Foundation ]
* http://digilander.libero.it/martini_syndrome/


{{Electrocardiography}}
{{Electrocardiography}}
Line 91: Line 60:
[[zh:布魯格達氏症候群]]
[[zh:布魯格達氏症候群]]
[[tr:Brugada sendromu]]
[[tr:Brugada sendromu]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[CME Category::Cardiology]]


[[Category:Electrophysiology]]
[[Category:Electrophysiology]]
Line 96: Line 69:
[[Category:Channelopathy]]
[[Category:Channelopathy]]
[[Category:Genetic disorders]]
[[Category:Genetic disorders]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 05:04, 20 August 2020

Brugada syndrome
ECG in Type I Brugada Pattern

For patient information, click here

Brugada syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Brugada syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Examples of Type I Brugada Syndrome

Chest X Ray

Echocardiography or Ultrasound

Electrophysiologic Studies

Genetic Testing

Treatment

Treatment

Drugs to Avoid

Drugs to Preferably Avoid

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brugada syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brugada syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brugada syndrome

CDC on Brugada syndrome

Brugada syndrome in the news

Blogs on Brugada syndrome

Directions to Hospitals Treating Brugada syndrome

Risk calculators and risk factors for Brugada syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Synonyms and keywords: Sudden unexpected death syndrome; sudden unexplained death syndrome; SUDS; sudden unexpected nocturnal death syndrome; sudden unexplained nocturnal death syndrome; SUNDS; in the Phillipines bangungut (to rise and moan in sleep); in Thailand lai tai; in Laos Dab tsog and in Japan Pokkuri disease

Overview

Classification

Historical Perspective

Pathophysiology

Differentiating Brugada syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Brugada syndrome diagnosis|Diagnosis

Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | Echocardiography or Ultrasound | Electrophysiologic Studies | Genetic Testing

Treatment

Medical Therapy | Drugs to Avoid | Drugs to Preferably Avoid | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters


de:Brugada-Syndrom it:Sindrome di Brugada he:תסמונת ברוגדה fi:Brugadan oireyhtymä


Template:WikiDoc Sources CME Category::Cardiology